Plus Therapeutics, Inc. (NASDAQ: PSTV) reported Q2 EPS of ($0.24), $0.01 worse than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Plus Therapeutics, Inc. (PSTV) click here.